1-4 of 4
Steffen Dörfel
Close
Sort by
Journal Articles

Real-World Outcomes with Ibrutinib in Patients with Chronic Lymphocytic Leukemia: Impact of Patient Typology on Adherence and Retention Rates within the German REALITY Study

Manfred Welslau, Sjaak Bloem, Rudolf Schlag, Steffen Dörfel, Sabrina Buchholz, Lukas Vornholz, Holger Schulz, Anke Gerhardt
Journal: Blood
Blood (2022) 140 (Supplement 1): 12400–12402.
https://doi.org/10.1182/blood-2022-156504
Published: 2022
Journal Articles

Treatment of Immune Thrombocytopenia (ITP) with Eltrombopag - Results of the 5 th Interim Analysis of the Study RISA, with Special Consideration of Treatment Discontinuations

Oliver Meyer, Rudolf Schlag, Thomas Stauch, Bastian Fleischmann, Marcel Reiser, Dietrich Kaempfe, Timo Behlendorf, Manfred Welslau, Eyck von der Heyde, Steffen Dörfel, Claudia Willy, Martina Stauch
Journal: Blood
Blood (2022) 140 (Supplement 1): 2683–2684.
https://doi.org/10.1182/blood-2022-166741
Published: 2022
Journal Articles

Fludarabine, Cyclophosphamide and Rituximab (FCR) As First Line Treatment in Patients with Chronic Lymphocytic Leukemia (CLL): A Long-Term Analysis of the German CLL Study Group (GCLLSG) Registry

Nadine Kutsch, Anna Maria Fink, Anno Federhen, Adam Giza, Sandra Robrecht, Janina Stumpf, Andrea Stoltefuß, Ursula Vehling-Kaiser, Michael Koenigsmann, Eugen Tausch, Christof Schneider, Stephan Stilgenbauer, Thomas Illmer, Rudolf Schlag, Steffen Dörfel, Tobias Gaska, Michael G. Kiehl, Kirsten Fischer, Barbara Eichhorst, Michael Hallek
Journal: Blood
Blood (2022) 140 (Supplement 1): 9879–9881.
https://doi.org/10.1182/blood-2022-169956
Published: 2022
Journal Articles

Good Tolerance of Lenalidomide Maintenance Therapy in Patients with High Risk Profile Chronic Lymphocytic Leukemia (CLL) after Frontline Chemoimmunotherapy: Preliminary Safety Overview of the CLLM1 Trial of the German CLL Study Group (GCLLSG)

Barbara Eichhorst, MD, Jasmin Bahlo, Anna Maria Fink, MD, Michael Pfreundschuh, Holger Hebart, MD, Georg Maschmeyer, MD, Kathleen Jentsch-Ulrich, MD PhD, Steffen Dörfel, Anne Westermann, Aline Zey, Kirsten Fischer, Clemens-Martin Wendtner, MD, Thomas Noesslinger, MD, Paolo Ghia, MD PhD, Francesc Bosch, MD PhD, Arnon P. Kater, MD PhD, Karl-Anton Kreuzer, MD, Hartmut Döhner, MD, Stephan Stilgenbauer, Sebastian Boettcher, MD, Michael Hallek, MD
Journal: Blood
Blood (2014) 124 (21): 4699.
https://doi.org/10.1182/blood.V124.21.4699.4699
Published: 2014